Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emese Kiss

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Orvosi Hetilap|January 10, 2006
[Analysis of paraoxonase activity and lipid profile in lupus patients]Emese Kiss, Ildikó Seres, Kocsis Zsolt, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single centerTünde Tarr, Balázs Gyorfy, Eva Szekanecz, et al.
Clinical Reviews in Allergy & Immunology|October 6, 2007
Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-upTunde Tarr, Gabriella Lakos, Harjit Pal Bhattoa, et al.
Current Medicinal Chemistry|December 17, 2014
Tissue-Specific Glucocorticoid Signaling May Determine The Resistance Against Glucocorticoids In Autoimmune DiseasesAgnes Szappanos, Zsolt Nagy, Balázs Kovács, et al.
Autoimmunity Reviews|August 12, 2019
The potential pathogenic role of glucocorticoid receptor polymorphisms in systemic lupus erythematosus and rheumatoid arthritisAnna Bazsó, Ágnes Szappanos, Annamária Kövesdi, et al.
Orvosi Hetilap|February 13, 2018
[Extraadrenal glucocorticoid synthesis]Ágnes Szappanos, Katalin Mészáros, Zsolt Nagy, et al.
Journal of Autoimmunity|November 8, 2006
Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patientsEmese Kiss, Pal Soltesz, Henrietta Der, et al.
Autoimmunity|July 24, 2009
Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosusPeter Szodoray, Tunde Tarr, Judit Tumpek, et al.
Journal of Autoimmunity|October 18, 2008
Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indicesEva Szekanecz, Gabriella Szucs, Zoltán Szekanecz, et al.
Clinical Immunology (Orlando, Fla.)|December 1, 2005
Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosusAndrea Sümegi, Péter Antal-Szalmás, Magdolna Aleksza, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Orvosi Hetilap|January 10, 2006
[Analysis of paraoxonase activity and lipid profile in lupus patients]Emese Kiss, Ildikó Seres, Kocsis Zsolt, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single centerTünde Tarr, Balázs Gyorfy, Eva Szekanecz, et al.
Clinical Reviews in Allergy & Immunology|October 6, 2007
Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-upTunde Tarr, Gabriella Lakos, Harjit Pal Bhattoa, et al.
Current Medicinal Chemistry|December 17, 2014
Tissue-Specific Glucocorticoid Signaling May Determine The Resistance Against Glucocorticoids In Autoimmune DiseasesAgnes Szappanos, Zsolt Nagy, Balázs Kovács, et al.
Autoimmunity Reviews|August 12, 2019
The potential pathogenic role of glucocorticoid receptor polymorphisms in systemic lupus erythematosus and rheumatoid arthritisAnna Bazsó, Ágnes Szappanos, Annamária Kövesdi, et al.
Orvosi Hetilap|February 13, 2018
[Extraadrenal glucocorticoid synthesis]Ágnes Szappanos, Katalin Mészáros, Zsolt Nagy, et al.
Journal of Autoimmunity|November 8, 2006
Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patientsEmese Kiss, Pal Soltesz, Henrietta Der, et al.
Autoimmunity|July 24, 2009
Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosusPeter Szodoray, Tunde Tarr, Judit Tumpek, et al.
Journal of Autoimmunity|October 18, 2008
Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indicesEva Szekanecz, Gabriella Szucs, Zoltán Szekanecz, et al.
Clinical Immunology (Orlando, Fla.)|December 1, 2005
Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosusAndrea Sümegi, Péter Antal-Szalmás, Magdolna Aleksza, et al.
Pageof 10